论文部分内容阅读
Grene therapy is an attractive approach for the causal treatment of diseases associated with genetic malfunction.Critical requirements are stable nucleic acid packaging,cellular uptake and subsequent vesicular escape from endolysosomes to reach the cytoplasm.Delivery systems designed for in vivo systemic administration must overcome also the nonspecific interactions of polyplexes (PEC) with cells of the immune system and blood plasma proteins during their transport to target cells.These obstacles can be successfully suppressed by modifying the surface of PEC with covalently linked hydrophilic polymers [1].